These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6117153)

  • 21. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.
    François C; Grabli D; McCairn K; Jan C; Karachi C; Hirsch EC; Féger J; Tremblay L
    Brain; 2004 Sep; 127(Pt 9):2055-70. PubMed ID: 15292054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Trabucchi M; Andreoli VM; Frattola L; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
    [No Abstract]   [Full Text] [Related]  

  • 23. Some normal and abnormal behavioral syndromes due to transmitter gating of opponent processes.
    Grossberg S
    Biol Psychiatry; 1984 Jul; 19(7):1075-118. PubMed ID: 6148110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What is the connection between Parkinson disease and tardive dyskinesia?].
    Gunne LM; Andrén PE
    Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug holiday in Huntington's disease.
    Schmidt EZ; Hofmann P; Kapfhammer HP; Bonelli RM
    Ann Pharmacother; 2005 Apr; 39(4):773. PubMed ID: 15741414
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Voice disorders caused by neurological diseases].
    Gamboa J; Jiménez-Jiménez FJ; Mate MA; Cobeta I
    Rev Neurol; 2001 Jul 16-31; 33(2):153-68. PubMed ID: 11562877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The subcortical regulatory motor system in the development and its disorders.
    Lesný I
    Acta Univ Carol Med Monogr; 1980; 96():1-74. PubMed ID: 7348097
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperattentional syndrome in children].
    Grippo J; Grippo T
    Rev Neurol; 2001 Dec 16-31; 33(12):1149-51. PubMed ID: 11785053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].
    Relja M; Lackvoić Z
    Lijec Vjesn; 1979 Oct; 101(10):609-16. PubMed ID: 44538
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcranial magnetic stimulation in movement disorders.
    Berardelli A
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 51():276-80. PubMed ID: 10590960
    [No Abstract]   [Full Text] [Related]  

  • 33. Impairment of optokinetic nystagmus in patients with tardive dyskinesia.
    Lipper S
    Arch Gen Psychiatry; 1973 Mar; 28(3):331-3. PubMed ID: 4143946
    [No Abstract]   [Full Text] [Related]  

  • 34. Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats.
    Negishi T; Kawasaki K; Sekiguchi S; Ishii Y; Kyuwa S; Kuroda Y; Yoshikawa Y
    Behav Brain Res; 2005 Apr; 159(2):323-31. PubMed ID: 15817195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?
    Zametkin AJ; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1987 Sep; 26(5):676-86. PubMed ID: 2889717
    [No Abstract]   [Full Text] [Related]  

  • 37. [A reversible disorder of the avoidance reaction as an experimental model for the study of the action of psychotropic preparations on higher nervous activity].
    Inozemtsev AN; Pragina LL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):764-6. PubMed ID: 2816063
    [No Abstract]   [Full Text] [Related]  

  • 38. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 39. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
    Lane EL; Vercammen L; Cenci MA; Brundin P
    Exp Neurol; 2009 Sep; 219(1):355-8. PubMed ID: 19393238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurobiology of attention deficit-hyperactivity disorder].
    Narbona-García J; Sánchez-Carpintero R
    Rev Neurol; 1999 Feb; 28 Suppl 2():S160-4. PubMed ID: 10778507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.